Category: 2018

Questrom School of Business Appoints One of Its Own as New Dean

Susan Fournier, a marketing and management professor at BU for 13 years and a leading international expert on brand marketing, will become the next dean of the Questrom School of Business, effective August 27. The first female dean to lead the business school, Fournier is credited with pioneering the brand relationships subfield in marketing, which […]

Ebola Research Begins at NEIDL

Eight months after receiving final approval from the Boston Public Health Commission to conduct research at Biosafety Level 4 (BSL-4), Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) has begun work with its first Level-4 pathogen, the Ebola virus. “This is clearly an important step for the NEIDL,” says Ronald B. Corley, NEIDL director and a School of […]

Fear and Suspicion Hinder Congo Medics in Ebola Battle

Reuters Nahid Bhadelia With more than twice as many Ebola outbreaks as any other country since the virus was discovered in 1976, Congolese are familiar with its destructive power, yet fear and suspicion of medical authorities are still hindering efforts at containment… Expert Quote: “By doing something violent you’d be creating greater distrust.” View full […]

Vaccines Alone Won’t Beat Ebola

The Atlantic Nahid Bhadelia Three people who had been infected with Ebola recently left an isolation ward at Wangata Hospital against medical advice, according to the Democratic Republic of the Congo’s Ministry of Health… Expert Quote: “Of course you want vaccines, but yellow fever and cholera are perfect examples of disease where we have vaccines […]

DRC: Experimental Ebola Vaccine to be Administered in Mbandaka

The Guardian Nahid Bhadelia Health authorities and NGOs in the Democratic Republic of the Congo will begin administering an experimental Ebola vaccine on Monday in Mbandaka, the north-western city of 1.2 million people where the deadly disease was detected last week… Expert Quote: “The vaccine is a powerful tool but you still need other tools. […]

BU-Based CARB-X Antimicrobial Partnership Gets Another $50 Million Plus

In a sign of the growing recognition of the threat of antibiotic resistance, the Bill & Melinda Gates Foundation and the UK government are joining CARB-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator), a BU-based public-private partnership launched two years ago by the US Department of Health and Human Services (HHS) to give financial, scientific, and […]